Sino Mdgene
Beijing
About Sino Mdgene
Sino Mdgene is committed to providing the clinic products and services. It has created various business segments, such as pharmacogenomics, pathogenic microbes, and tumour liquid biopsy. They offer early tumour screening, targeted drug detection for cancers, tumour drug resistance monitoring, and other services.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2018)
- Website: sinomdgene.com
- Phone: +86 10 6781 0661
Industries & Categories
Consulting, Information Technology, Robotics
Canonical: https://fsome.com/organization/sino-mdgene-132704 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.